The Scientific World Journal

Research Article

Formulation and Evaluation of Guggul Lipid Nanovesicles for Transdermal Delivery of Aceclofenac

Table 1

Composition of the nanovesicle formulations (lipid drug ratio = 3 : 1).
S. No.Formulation codeCompositionMolar ratio
(% w/w)
1.PC-1PC/Chol/DCP7/3/1
2.PC-2PC/Chol/DCP5/3/1
3.PC-3PC/Chol/DCP3/3/1
4.GL-1GL/Chol/DCP7/3/1
5.GL-2GL/Chol/DCP5/3/1
6.GL-2GL/Chol/DCP3/3/1
PC: Phosphatidylcholine nanovesicle; GL: Guggul Lipid nanovesicle; Chol: cholesterol; DCP: Dicetyl phosphate.